325700login-checkImplant reverses type 1 diabetes in mice by delivering beta cells |
Some of the most favorable alternative sources for diabetes cell replacement therapy are human stem cells. However, a critical challenge has been finding a safe, effective means to introduce replacement cells that normalize blood sugar levels without triggering the body’s natural immune response.
Researchers at the Washington University School of Medicine in St. Louis, MO, and Cornell University in Ithaca, NY, have collaborated to develop a tiny implant that successfully delivers insulin-secreting cells, or beta cells, into mice with diabetes, without the need for immunosuppressive drug treatment.
Read more, here.
325700login-checkImplant reverses type 1 diabetes in mice by delivering beta cells |